Ethnic differences on long term outcomes of polypoidal choroidal vasculopathy after predominantly bevacizumab monotherapy

Ethnic differences on long term outcomes of polypoidal choroidal vasculopathy after predominantly bevacizumab monotherapy

Abstract Background A 3-year single-centre, retrospective, comparative, non-randomized cohort study to describe the long-term outcomes of treatment-naïve, Caucasian and non-Caucasian eyes with polypoidal choroidal vasculopathy (PCV) after treatment with predominantly Bevacizumab monotherapy or in co...

Full description

Bibliographic Details
Main Authors: Aaron Yap, Nancy Wang, David Squirrell
Format: Article
Language:English
Published: BMC 2022-07-01
Series:BMC Ophthalmology
Subjects:
Polypoidal choroidal vasculopathy
Bevacizumab
Treatment outcomes
Real-world study
Long term
Online Access:https://doi.org/10.1186/s12886-022-02551-3

Internet

https://doi.org/10.1186/s12886-022-02551-3

Similar Items